About PROCEPT BioRobotics

PROCEPT BioRobotics develops robotic surgical systems for treating benign prostatic hyperplasia, a condition affecting millions of men. Their Aquablation therapy combines ultrasound imaging, robotic precision and waterjet ablation to remove prostate tissue while preserving sexual and urinary function. The AI powered HYDROS Robotic System enables surgeons to deliver personalised care across prostates of all shapes and sizes. Founded in Silicon Valley, PROCEPT partners with urologists globally to redefine BPH care. Their technology offers men effective symptom relief without the compromises of traditional surgery. By equipping physicians with evidence backed tools, PROCEPT improves patient outcomes and sets new standards in urological care.